New clinical service agreement between OHSU and DermDetect will allow the researchers at OHSU to color-code the ASCS images using the PACS Workstation and DermCloud technology provided by DermDetect. Academic Dermatologist log-in to the DermCloud from anywhere in the world using the secure encrypted PACS technology that brings DICOM to dermatology for the first time.
DermDetect signs Clinical Service Agreement with OHSU to provide color-code for ASCS participants.
Colorado has the highest per-capita rate of skin cancer, thanks to sunshine and high elevation
Nevus count tied to BCC risk
REPORTING FROM IID 2018 – Dematology News, presented by
ORLANDO – The more nevi a person has, the greater the risk of basal cell carcinoma, according to a review of over 200,000 subjects in decades-long health professional cohorts. It’s well known that nevi increase the risk of melanoma, and the study confirmed that fact. The basal cell carcinoma finding, however, is novel. “The relationship between nevi and non-melanoma skin cancer has not [previously] been clearly demonstrated in large population cohorts,” said lead investigator Erin X. Wei, MD, a dermatologist at Brigham and Women’s Hospital, Boston. “Nevus count serves as a convenient maker to identify patients at risk for both melanoma and basal cell carcinoma. Providers should be aware of these increased risks in patients with any nevi on the extremity, particularly 15 or more,” she said at the International Investigative Dermatology meeting. Read the article here…..